MPL Y252H and MPL F126fs mutations in essential thrombocythemia: Case series and review of literature

Main Article Content

Ahmed G. Elsayed *
Aeesha Ranavaya
Muhammad Omer Jamil
(*) Corresponding Author:
Ahmed G. Elsayed |


Essential thrombocythemia (ET) is a clonal bone marrow disease, characterized by increased production of platelets along with other clinical and bone marrow findings. Most patients with ET will have a somatic mutation in one of the known gene locations of JAK2, CALR , or MPL that can upregulate the JAK-STAT pathway. MPL mutation is present in 5% of cases with the most common mutations being W515L and W515K. In this report we describe 2 cases of patients with clinical and laboratory picture of ET. One patient carried MPLY252H mutation which is previously unreported in the adult population but has been shown to be a gain-of-function mutation. The other patient carried MPL F126fs mutation which is not known to be of clinical importance and has not been previously reported.

Downloads month by month


Download data is not yet available.

Article Details